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Abstract
Mutations of the Wnt5a gene, encoding a ligand of the non-canonical Wnt pathway, and the Ror2 gene, encoding its
receptor, have been found in patients with cardiac outflow tract defects. We found that Wnt5a is expressed in the second
heart field (SHF), a population of cardiac progenitor cells destined to populate the cardiac outflow tract and the right
ventricle. Because of cardiac phenotype similarities between Wnt5a and Tbx1 mutant mice, we tested potential interactions
between the two genes. We found a strong genetic interaction in vivo and determined that the loss of both genes caused
severe hypoplasia of SHF–dependent segments of the heart. We demonstrated that Wnt5a is a transcriptional target of Tbx1
and explored the mechanisms of gene regulation. Tbx1 occupies T-box binding elements within the Wnt5a gene and
interacts with the Baf60a/Smarcd1 subunit of a chromatin remodeling complex. It also interacts with the Setd7 histone
H3K4 monomethyltransferase. Tbx1 enhances Baf60a occupation at the Wnt5a gene and enhances its H3K4
monomethylation status. Finally, we show that Baf60a is required for Tbx1–driven regulation of target genes. These data
suggest a model in which Tbx1 interacts with, and probably recruits a specific subunit of, the BAF complex as well as
histone methylases to activate or enhance transcription. We speculate that this may be a general mechanism of T-box
function and that Baf60a is a key component of the transcriptional control in cardiac progenitors.
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Introduction
The second heart field (SHF) provides progenitor cells for the
development of several segments of the mature heart, such as the
outflow tract, right ventricles and atria [1,2]. Mouse models of
congenital heart disease suggest that perturbation of SHF
development may be the basis of relatively common heart defects
in humans, such as conotruncal anomalies, but the transcriptional
mechanisms driving SHF development are not well defined. An
important example of a congenital heart disease gene that functions
withinthe SHFis TBX1encodinga T-box transcriptionfactor. This
is haploinsufficient in the DiGeorge/Velocardiofacial/22q11.2
deletion syndrome, which is associated with various types of cardiac
outflow tract (OFT) and vascular defects [3]. Tbx1 mouse mutants
recapitulate well the human phenotype, which has facilitated a
detailed analysis of the role of the gene in heart development. In
particular, Tbx1 is expressed in the SHF where it sustains cell
proliferation and inhibits differentiation [4]. However, there is
considerable less information about the effectors of these develop-
mental roles, and about the mechanisms for target gene regulation.
SHF cardiac progenitors, which reside outside the heart, are
thought to migrate into the heart and differentiate as they are
incorporated into the OFT. Thus, it is reasonable to expect that
transcriptional regulation of SHF progenitors should involve cell
polarity and cell migration, functions that in many cases are
regulated by the non-canonical Wnt pathway [5]. Here we show
that Wnt5a, which encodes a ligand of the non-canonical pathway,
is expressed in the SHF. It has been shown that Wnt5a
2/2 animals
have OFT abnormalities, though generally not as severe as in
Tbx1
2/2 animals [6]. In addition, OFT defects have also been
shown in Ror2
2/2 mice, Ror2 being a receptor of Wnt5a.
Furthermore, mutations of WNT5a or ROR2 in humans are
associated with Robinow syndrome [7], which includes OFT
defects, though at a low penetrance. Therefore, we postulated that
there may be interaction between Tbx1 and the non-canonical
Wnt pathway. We have crossed Tbx1 and Wnt5a mouse mutants
and found that there is indeed a genetic interaction and, most
interestingly, the loss of both genes caused developmental failure of
the SHF-dependent heart segments, indicating that the two genes
are required for SHF function. Next, we investigated the
transcriptional mechanisms underlying this interaction. We found
that Wnt5a is a transcriptional target of Tbx1. Previous data
showing a genetic interaction between Tbx1 and the gene
encoding the chromodomain protein Chd7 [8] and physical
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us to investigate the role of chromatin remodeling and histone
modifiers. We found that Tbx1 co-immunoprecipitates with
Baf60a, a component of the SWI-SNF-like BAF chromatin
remodeling complex, and with the Setd7 histone 3, Lysin 4
monomethyltransferase. Tbx1 expression increases the occupation
of the Wnt5a gene by Baf60a, and enhances the H3K4
monomethylation status of the chromatin in the T-box binding
element (TBE)-harboring regions of the Wnt5a gene. Finally, we
found that Baf60a is required for Tbx1-induced regulation of
Wnt5a. Overall, our data support a mechanism by which Tbx1
enhances transcription of Wnt5a (and possibly other target genes)
by interacting with a chromatin remodeling complex and
enhancing H3K4 de novo methylation.
This is the first evidence of an impact of Tbx1 on chromatin
status and of its interaction with the BAF complex. Our data also
raises the intriguing possibility that Baf60a is a critical BAF subunit
for the transcriptional program of cardiac progenitors.
Results
Wnt5a is regulated by Tbx1 in the SHF
We carried out in situ hybridization of Wnt5a in embryos from
E8.0 to E11.5 and found strong expression in the pharyngeal and
splanchnic mesoderm including the SHF region (Figure 1). In
addition, we found expression in the OFT, as previously noted
[6,10]. We next tested whether Wnt5a expression may be altered
by Tbx1 mutation. At E8.0–8.5, Wnt5a expression was reduced in
the SHF of Tbx1
2/2 embryos (n=3; Figure 1), while it was not
affected in the OFT or pharyngeal arch core mesoderm (Figure 1).
3D reconstruction analysis of section images provides an overall
view of the expression domains affected by loss of Tbx1 (Figure 1K–
1P). Similar results were obtained at later stages (E9.0–11.5, not
shown).
To confirm that Wnt5a is expressed in cardiac progenitors, we
carried out qRT-PCR on the P19CL6 mouse embryonal
carcinoma cell line that is able to differentiate into cardiomyocyte
progenitors upon 5-azacytidine and/or DMSO treatment [11].
We found that Wnt5a is robustly expressed after 3 days of
differentiation (Figure S1). The activation of Wnt5a expression
roughly coincides with the up-regulation of Tbx1 expression,
suggesting that Tbx1 may have a role in the activation of Wnt5a
rather than in its expression maintenance. We also found that loss
of Wnt5a in these cells reduces cell migration, as tested by a
wound-healing assay (Figure S2). Next we tested if Tbx1 can
regulate Wnt5a expression in these cells. For this, we transfected
graded amounts of a Tbx1-expressing vector into P19CL6
undifferentiated cells and evaluated expression of the endogenous
Wnt5a gene by qRT-PCR. Results revealed that Wnt5a expression
responds positively to Tbx1 in a dosage-dependent manner (Figure
S3).
Tbx1 and Wnt5a interact genetically and their combined
loss causes failure of SHF–derived structures
To test whether Wnt5a and Tbx1 interact in vivo, we crossed
Tbx1
+/2;Wnt5a
+/2 mice and determined the embryonic pheno-
type on the progeny at E18.5. Results of the analysis of 162
embryos are summarized in Tab. 1. Double heterozygous embryos
(Tbx1
+/2;Wnt5a
+/2, n=61) showed higher penetrance of the
typical Tbx1 haploinsufficiency phenotype (hypoplasia or aplasia of
the 4th pharyngeal arch artery) than did the Tbx1
+/2 embryos
(n=17) (44.3% vs. 23.5%, p,0.05). However, we did not find any
additional phenotypic abnormalities in double heterozygous
embryos. We did not find any cardiovascular abnormality in
Wnt5a
+/2 embryos (n=30) consistent with previously reported
data [6].
Analysis of Wnt5a
2/2 embryos (n=5) revealed ventricular
septal defects (VSD) and abnormal positioning of the great arteries
(aorta and pulmonary trunk), which were side-by-side (Figure 2B–
2D). However, in none of these embryos did we observe truncus
arteriosus communis (TAC), although this defect was previously
reported for most Wnt5a
2/2 embryos [6]. This difference may be
due to different genetic backgrounds. However, the extracardiac
phenotype that we found was consistent with previously reported
data (cleft palate, cleft lip, small thymus, truncated tail and limbs)
(Figure 2A and data not shown). Analysis of Tbx1
+/2;Wnt5a
2/2
embryos (n=22) revealed a more severe phenotype than in
Wnt5a
2/2 embryos from the same crosses. In particular, out of 22
embryos examined, 13 (59%) showed additional abnormalities
compared to Wnt5a
2/2 embryos, namely TAC, small ear and
edema (Figure 2A9–2D9). The other embryos (9 out of 22 or 41%)
were phenotypically indistinguishable from Wnt5a
2/2 embryos.
Together, these results indicate a genetic interaction between Tbx1
and Wnt5a.
We did not retrieve any double homozygous embryos at E18.5
(n=162), suggesting that this genotype is lethal during early
embryogenesis. Therefore, we harvested embryos at earlier
embryonic stages. The latest stage at which we found live
Tbx1
2/2; Wnt5a
2/2 embryos was E9.5. At this stage, double
homozygous embryos (n=10) showed a severe cardiac phenotype
characterized by severe hypoplasia of the OFT and right ventricle
(RV), structures that sometimes appeared to be absent by visual
inspection (Figure 3). Histological sections confirmed that the
development of these structures is severely affected (Figure 3A0–
3D0). We carried out in situ hybridization with a probe for
CyclinD2, a marker of the proximal OFT and the right ventricle
(RV) [12]. Results showed that CyclinD2 was normally expressed in
control, Tbx1
2/2 and Wnt5a
2/2 E9.5 embryos, but it was greatly
reduced orundetectable inTbx1
2/2;Wnt5a
2/2 embryos (Figure4),
confirming the severe hypoplasia of the OFT and of the RV. We
asked whether the hypoplasia of these structures could be due to
increased apoptosis. We carried out immunohistochemistry on
E9.5 embryos using an anti-cleaved Caspase 3 antibody. Results
showed very few positive cells in the OFT and RV of WT and
Author Summary
We have demonstrated a novel interaction between the
Tbx1 gene, the mutation of which causes DiGeorge
syndrome, and Wnt5a, another human disease gene,
which is important for oriented cell migration and cell
polarity. We found that, in mice, reduced dosage of each of
the two genes enhances the phenotype caused by the
mutation of the other. Loss of the two genes in mice has
very severe consequences for heart development. Our
genetic and biochemical data determined that Tbx1, a
transcription factor of the T-box family, regulates Wnt5a
expression. We found that Tbx1 targets the BAF chromatin
remodeling complex to the Wnt5a gene and interacts with
a histone monomethyltransferase. Tbx1 expression increas-
es Baf60a occupation of the Wnt5a gene and enhances its
H3K4 monomethylation status, while Baf60a knockdown
abolishes the ability of Tbx1 to regulate Wnt5a and other
target genes. Overall, our data identify Wnt5a as an
important effector of Tbx1 function in heart development
and demonstrate that Tbx1 regulates the gene by
interacting with the chromatin remodeling and histone
methylation machinery.
Tbx1 Function and Chromatin
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2/2 E9.5 embryos, while both Wnt5a
2/2 and Tbx1
2/2;
Wnt5a
2/2 embryos exhibited an increased number of apoptotic
cells (Figure 5A–5D). However, we found no obvious difference in
apoptosis between Wnt5a
2/2 and Tbx1
2/2;Wnt5a
2/2 embryos.
Therefore, it is unlikely that apoptosis explains the severe heart
phenotype of double mutants.
It has been reported that there is antagonism between the non-
canonical and canonical Wnt pathways (e.g. [13,14]). Therefore,
we asked whether there could be alterations of b-catenin
expression in our mutants. By immunofluorescence, b-catenin
expression in the SHF did not change in Tbx1
2/2 or Wnt5a
2/2
embryos at E9.5 (Figure 5F–5G and 5F9–5G9), but it was
upregulated in the SHF of Tbx1
2/2;Wnt5a
2/2 embryos
(Figure 5H–5K and 5H9–5K9).
Wnt5a is a target of Tbx1
To understand whether Wnt5a may be a direct target of Tbx1,
we searched for T-Box binding elements (TBEs) in a 20 kbp
genomic sequence encompassing the mouse Wnt5a gene. We
found three putative TBEs, two of which closely located in intron
3–4 (TBE1: AAGGGGTGAA, TBE2: GTAGGTGCCAGG) and
one in the 39-UTR (TBE3: AGAGGTGTTGCA) (Figure 6A). We
next cloned two evolutionarily conserved (in human and mouse)
DNA segments containing TBE1–2 and TBE3, into a luciferase
reporter plasmid with a basic promoter (Figure 6B–6C). We also
generated mutagenized constructs in which the three TBEs were
mutated (the core sequence GTG was changed into AAA). We
then carried out luciferase assays. Results showed that the two
DNA segments responded well to transfected Tbx1 (Figure 6B–
6C). However, mutation of the TBEs, individually or combined,
all had a significant impact on the ability of Tbx1 to activate the
constructs (Figure 6B–6C), although the mutation of TBE1 had a
relatively lower effect. Thus, these TBEs are required for Tbx1-
induced activation in this assay.
Next, we tested whether the endogenous Tbx1 protein occupies
these TBE sites in P19Cl6 cells by standard and quantitative
chromatin immunoprecipitation (ChIP) assays using a Tbx1
antibody. TBE1 and TBE2 were assayed together because they
are too close to be assayed independently. Results demonstrated
that indeed these sites are occupied by endogenous Tbx1 in
P19CL6 cells (Figure 7A–7B). Next, we repeated the same assay
using chromatin from E9.5 wild type embryos and again we could
demonstrate enrichment at the Wnt5a TBE loci (Figure 7C).
Tbx1 interacts with the BAF chromatin remodeling
complex and with the Setd7 histone methyltransferase
To begin to dissect the transcriptional machinery within which
Tbx1 exerts its transcriptional functions, we tested by co-
immunoprecipitation (co-IP) or affinity purification chromatin
remodeling and histone modification proteins, Baf60a, Baf60c,
Baf155, Setd7 and p300. Under the experimental conditions
tested, we found that Baf60a and Setd7, but not Baf60c, Baf155
and p300, co-immunoprecipitated with Tbx1 (Figure 8 and Figure
S4A)). The Baf60a-Tbx1 interaction was also confirmed using a
GST pull down assay (Figure S4B). Furthermore, we confirmed
Baf60a-Tbx1 co-IP using E9.5 embryo tissues (Figure 9A). At this
stage, the Baf60a gene is expressed broadly, including the SHF, but
is very weakly expressed or absent in the heart (Figure 9B). In
Figure 1. Wnt5a is expressed in the second heart field (SHF) and is downregulated in Tbx1
2/2 embryos. (A–D9) The expression of Wnt5a
was downregulated in the SHF, but not in the outflow tract (OFT) or the pharyngeal arch (PA) core mesoderm of Tbx1
2/2 embryos at E8.0–11.5 (A9–
D9), compared with the littermate controls (A–D), shown by whole-mount in situ hybridization (n=3). Right view; arrowheads indicate the SHF. (E–J9)
Transverse or sagittal sections cut from whole-mount in situ hybridized E8.0–9.0 Tbx1
2/2 embryos (F, H, J) showed the downregulation of Wnt5a
expression, compared with the littermate control (E, G, I, n=3); squared regions are magnified on the adjacent panels; arrows indicate the SHF/
splanchnic mesoderm domain. Arrowheads on panel E9 indicate a mesodermal expression domain strongly affected by the loss of Tbx1. (K–P) 3D
reconstructions of E8.0 WT and Tbx1
2/2 embryos provide a schematic, overall view of the expression domains regulated by Tbx1. Reconstructions
were built using sections from embryos shown in E and F. Arrows indicate the SHF. PA: pharyngeal arch; OFT: outflow tract; SHF: second heart field;
RV: right ventricle; ST: somite; NT, notochord; RA, right atrium; V: common ventricle; LV, left ventricle. Scale bars: 100 mm.
doi:10.1371/journal.pgen.1002571.g001
Table 1. Summary of phenotyping results of E18.5 embryos from Tbx1
+/2;Wnt5a
+/2 X Tbx1
+/2;Wnt5a
+/2 intercrosses.
E18.5 n
Normal
(%) Dead
AoA
Abn
Ao-PT
side by
side + VSD TAC + VSD
WT 5 5 (100) - - - -
Tbx1+/2 17 13 (76) - 4 (23%) - -
Wnt5a+/2 30 30 (100) - - - -
Tbx1+/2; Wnt5a+/2 61 34 (56) 2 25 (41%) - -
Tbx1+/2; Wnt5a 2/2 22 -- -9 1 3
Tbx12/2 7 -- -- 7
Wnt5a2/2 5 -- -5 -
Tbx12/2; Wnt5a+/2 15 -- -- 1 5
Tbx12/2; Wnt5a2/2 0 -- -- -
Total 162
AoA Abn: Abnormalities of the aortic arch and of the origin of the right subclavian artery.
Ao-PT: abnormal relative position of the aorta and pulmonary trunk, arranged side-by-side.
VSD: Ventricular septal defect, perimembranous.
TAC: Truncus arteriosus communis.
doi:10.1371/journal.pgen.1002571.t001
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mainly expressed in the heart and somites, and it has been
previously shown to interact with another T-box transcription
factor, Tbx5 [15]. While Tbx1 is mainly required in cardiac
progenitors, where it is important to keep cells proliferating and to
inhibit their differentiation, Tbx5 is important for cardiomyocyte
differentiation. We compared expression of Tbx1, Baf60a and
Baf60c mRNA during P19Cl6 cell differentiation. Results showed
that Tbx1 is expressed in the early phases of differentiation. Baf60a
is particularly strong in these early phases and then its expression is
reduced (although still robustly expressed). In contrast, Baf60c
expression is very low in the early phases of differentiation and
becomes quite strongly expressed as differentiation proceeds
(Figure 1).
If the Baf60a-Tbx1 interaction were a feature of the
transcriptional machinery at target genes, we would expect Baf60a
to occupy the regions of the Wnt5a gene harboring the TBEs. To
test this, we used ChIP with a Baf60a antibody on P19CL6 cells.
Results demonstrated that indeed this protein occupies the TBE1/
2 region as well as the TBE3 region (Figure 10A). The same results
were obtained with a ChIP assay using chromatin from E9.5
embryos (Figure 10B).
Tbx1 affects the chromatin status of TBE regions of
Wnt5a and requires Baf60a for its function
Given the interactions with the BAF complex and with Setd7,
we postulated that Tbx1 would recruit Baf60a to the target gene
and would affect histone methylation. Indeed, quantitative ChIP
using a Baf60a antibody showed that Tbx1 increases significantly
the enrichment of Wnt5a TBE sequences (Figure 10C). Thus,
increased dosage of Tbx1 is sufficient to enrich the Wnt5a gene
with a chromatin remodeling complex. Next, we asked whether
Tbx1 dosage can modulate H3K4me1 at TBE regions of the
Wnt5a gene. To this end, we carried out quantitative ChIP with an
anti H3K4me1 antibody (Setd7 is a monomethyltransferase) on
P19Cl6 cells transfected with Tbx1. Results indicated that there is
indeed enrichment of H3K4me1 after increased dosage of Tbx1
(Figure 11A–11B). Next, we tested whether H3K4me1 is also
affected by loss of Tbx1 in vivo. To this end, we carried out qChIP
assays using chromatin from WT and Tbx1
2/2 E9.5 embryos.
Results indicated that there is a significantly higher enrichment of
H3K4me1 in WT embryos compared to mutant embryos, but
limited to the TBE1/2 locus (Figure 11C).
Next, we tested additional histone H3 modifications associated
with gene activation. In particular, we carried out qChIP using
chromatin from P19Cl6 cells transfected with an empty vector or
with a vector over-expressing Tbx1 using antibodies against
H3K4me2, H3K4me3, or AcH3 (recognizing acetylation of
histone 3). Results indicated that none of these modifications are
enriched in correspondence of the TBE loci of the Wnt5a gene,
regardless of Tbx1 transfection (Figure 12).
Finally, we asked whether Baf60a is important for Tbx1-
induced upregulation of the Wnt5a gene. To this end, we knocked-
down Baf60a expression by RNA interference and determined the
ability of Tbx1 to regulate Wnt5a in the presence of reduced
Baf60a dosage in P19CL6 cells. Results showed that after a knock
down of approx. 80% of Baf60a, Tbx1 was unable to regulate
Wnt5a (Figure 13). Interestingly, without Baf60a, Tbx1 was not
able to activate other candidate targets (Fgf8, Fgf10 and Cyp26a1)
indicating that Baf60a is required for Tbx1 transcriptional activity
Figure 2. Tbx1 and Wnt5a interact genetically. (A–A9) Extracardiac phenotypes in Wnt5a
2/2 embryos included cleft palate, cleft lip, small
thymus, truncated tail and truncated limbs at E18.5 (A, n=5). In addition to the extracardiac phenotypes seen in Wnt5a
2/2 embryos, Tbx1
+/2;
Wnt5a
2/2 embryos had small ears and edema at E18.5 (A9, n=22). (B–D9) Coronal sections of the heart revealed ventricular septal defects (VSD) and
abnormal (side-by-side) positioning of the ascending aorta (AAo) and pulmonary trunk (PT) in Wnt5a
2/2 embryos (B–D, n=5). 13 out of 22 (59%)
Tbx1
+/2; Wnt5a
2/2 embryos showed truncus arteriosus communis (TAC), which was not observed in the Wnt5a
2/2 littermate (B9–D9). T: truncus
arteriosus communis. Scale bars: 1 mm in A–B9; 100 mm in C–D9.
doi:10.1371/journal.pgen.1002571.g002
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the basal expression of endogenous Tbx1, Wnt5a, Fgf8, Fgf10 and
Cyp26a1 in control experiments (Figure S5).
Discussion
This work identifies Wnt5a as a novel and important
transcriptional target of Tbx1. Combined loss of the two genes
caused severe hypoplasia of SHF-derived heart segments, and
early embryonic lethality. This is a much more severe phenotype
than that caused by loss of the individual genes. The exact cause of
the dramatic heart phenotype will require further investigation.
However, our data suggest at least two possible mechanisms. Loss
of Tbx1 impairs the ability to expand the heart progenitors pool of
the SHF [16], the loss of Wnt5a impairs their ability to migrate
(and/or to be correctly orientated) into the heart. Thus, a double
loss would essentially amount to a double hit upon cardiac
progenitors, which would be fewer in number and less capable of
contributing to the heart. Another possible cause of the severe
phenotype might be an interference with the Wnt canonical
signaling pathway in the double mutants, as suggested by the
observed upregulation of b-catenin expression. Constitutive
activation of Wnt canonical signaling in the SHF leads to severe
heart abnormalities that are similar to those observed in the
double homozygous mutants [17].
The importance of the non-canonical Wnt signaling for OFT
development has already been illustrated by the study of Wnt11
mouse mutants [18]. Wnt5a and Wnt11 are both expressed in the
OFT but, in contrast to Wnt5a, Wnt11 is not expressed in the SHF.
It would be interesting to cross the two mutants to see whether
there is functional redundancy in the OFT proper.
Because of the clear in vivo importance of the Tbx1-.Wnt5a
transcriptional control for SHF function, we decided to focus our
attention on the mechanisms regulating this control, as a possible
paradigm for transcriptional control in the SHF.
We found an interaction between Tbx1 and Baf60a. The latter
is a component of the BAF (Brg1-Brm Associated Factor) complex,
which is related to the yeast and fly SWI-SNF chromatin
remodeling complex. The canonical function of the BAF complex
is to utilize its ATPase activity to rearrange the nucleosome
distribution of chromatin, thus playing a crucial role in regulating
accessibility to components of the transcriptional machinery, and
thereby gene expression, either positively or negatively [19]. One
of the critical issues concerning the biology of the BAF complex, is
how it is targeted to genes that need to be regulated, i.e. how is
specificity achieved despite the apparent homogeneity of the core
Figure 3. Tbx1
2/2;Wnt5a
2/2 embryos have severe cardiac abnormalities. (A–D9) Whole mount histology study showed reduced overall size of
Tbx1
2/2; Wnt5a
2/2 embryos at E9.5 (n=10), compared with control (WT), Tbx1
2/2 or Wnt5a
2/2 littermates. (A0–D0) Sagittal sections of these embryos
revealed severe hypoplasia of the OFT and the right ventricle (RV) in the Tbx1
2/2; Wnt5a
2/2 embryos. Scale bars: 100 mm.
doi:10.1371/journal.pgen.1002571.g003
Tbx1 Function and Chromatin
PLoS Genetics | www.plosgenetics.org 6 March 2012 | Volume 8 | Issue 3 | e1002571Figure 4. Tbx1
2/2;Wnt5a
2/2 embryos have severe hypoplasia of SHF–derived heart. (A–D9) Right view (A–D) and frontal view (A9–D9)o f
Tbx1
2/2; Wnt5a
2/2 embryos hybridized in situ with a cyclin D2 probe showed severe hypoplasia of the OFT and the RV at E9.5, compared with
littermate controls. (A0–D0) Sagittal sections from whole-mount embryos hybridized with the cyclin D2 probe confirmed the severe cardiac defect in
Tbx1
2/2; Wnt5a
2/2 embryos. (A90–D90) high magnification of the regions identified with a square in panels A0–D0. Scale bars: 100 mm.
doi:10.1371/journal.pgen.1002571.g004
Figure 5. b-Catenin is upregulated in the SHF of Tbx1
2/2;Wnt5a
2/2 embryos at E9.5. (A–D) Immunohistochemistry using an anti-cleaved
Caspase 3 antibody showedno obvious difference in apoptosis between Wnt5a
2/2 andTbx1
2/2; Wnt5a
2/2 embryosat E9.5. (E–K) Immunofluorescence
using a b-catenin antibody showed no change of expression in the SHF (arrows) of Tbx1
2/2 or Wnt5a
2/2 embryos (E–G), while it was strongly
upregulated in the SHF of Tbx1
2/2; Wnt5a
2/2 embryos at E9.5 (H–K panels from independent embryos). Squared regions are magnified in the bottom
row of panels (E9–K9). Red: b-catenin; Blue: DAPI. PE: pharyngeal endoderm; OFT: outflow tract; RA: right atrium; Scale bars: 100 mm.
doi:10.1371/journal.pgen.1002571.g005
Tbx1 Function and Chromatin
PLoS Genetics | www.plosgenetics.org 7 March 2012 | Volume 8 | Issue 3 | e1002571components of the complex. One possibility is that specificity is
provided by non-core subunits and by the recruitment activity
operated by transcription factors that target specific genes. Our
ChIP data suggest that this may be the case, as Tbx1 appears to
recruit a BAF subunit onto the Wnt5a gene. Interaction with a
histone methyltransferase would further help transcription, for
example by stabilizing the remodeling machinery on the locus. We
show that indeed Tbx1 expression correlates with increased H3K4
monomethylation of the Wnt5a TBE loci in cultured cells and in
vivo. Interestingly, Tbx1 co-immunoprecipitates with Baf60a but
not Baf60c. These are two alternative subunits of the BAF
complex, possibly associated with different target genes and
different cellular differentiation states. Baf60a has been associated
with undifferentiated/multipotent status [20,21], while Baf60c has
Figure 6. Wnt5a has conserved T-box binding elements (TBEs) that are required for response to Tbx1 in luciferase assays. (A)
Schematic illustration of three conserved TBEs of the mouse Wnt5a gene. (B–C) Mutation of the TBEs, indicated as TBE D1, D2, D3, individually or
combined, significantly reduced the ability of Tbx1 to activate the Wnt5a luciferase reporters in JEG3 cells. Note that the TBE D1 mutation has a
relatively mild effect but still significant. Asterisks indicate statistically significant difference (P-value less than 0.05) between the WT value and the
Mutant value for each Tbx1 dosage.
doi:10.1371/journal.pgen.1002571.g006
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skeletal) [22,23]. We also show here that Baf60a tends to be
downregulated during P19Cl6 cell differentiation, while Baf60c is
upregulated. This finding is supported by in vivo expression data
indicating that Baf60a is poorly represented in differentiated heart
tissue in contrast to Baf60c, which is mostly expressed in heart and
somite tissue [15]. Thus, it is possible that an exchange of BAF
subunits plays a role in the passage from the progenitor state to the
differentiated cardiomyocyte state. Exchange of BAF subunits has
already been described during differentiation from neural
progenitors to neurons (Baf53a to Baf53b, and Baf45a to Baf45b)
[24].
Exactly what promoters or enhancers exchange BAF subunits
during cardiac differentiation would be an interesting question to
address using genome-wide ChIP-seq studies.
Setd7 is a H3K4 monomethyltransferase [25–27] already
shown to interact with another T-box transcription factor named
Tbx21 (also known as Tbet) [28]. It is thus tempting to speculate
that interaction with the BAF complex and histone methyltrans-
ferases is a common feature of T-box proteins and at the core of
the transcriptional function of these important transcription
factors.
Interestingly, our tissue culture experiments evidentiated that
Tbx1 has a positive effect on H3K4me1 enrichment, but not
H3K4me2, H3K4me3, or H3 acetylation. This suggests that Tbx1
promotes de novo methylation H3K4 at TBE enhancers perhaps
making them a target for additional regulators.
Overall, our data support a model by which Tbx1 regulates
Wnt5a by interacting with and perhaps recruiting a specific subunit
of the BAF complex, along with the histone modifier enzyme
Setd7, resulting in activation or enhancement of transcription of
the target gene. While a number of important molecular details
remain to be clarified, our data using a tissue culture model
indicate the importance of Baf60a for Tbx1-induced regulation of
Wnt5a and perhaps other target genes. Hence it is reasonable to
speculate that this BAF subunit is a key cofactor for Tbx1 function
in cardiac progenitors.
Materials and Methods
Ethics statement
All animal experimentations were carried out according to
animal welfare regulations and guidelines of the USA and of the
European Union.
Mouse lines
We used the mouse lines Tbx1
+/lacZ (here cited as Tbx1
+/2) [29],
available through the EMMA repository, and Wnt5a
+/2 [10]
Figure 7. Tbx1 occupies the TBEs of Wnt5a in P19Cl6 cells. Chromatin immunoprecipitation (ChIP) assays of P19Cl6 using an anti-Tbx1
antibody. (A) Standard PCR results using primers for the TBE1–2 and the TBE3 regions of Wnt5a. Amplification is clearly visible from the Tbx1-
immunoprecipitated material and from the input sample but not from the IgG-immunoprecipitated material (negative control). (B) Quantitative ChIP
assay (q-ChIP) on a similar experiment as the one shown in (A) but followed by quantitative real-time PCR. (C) Q-ChIP assay of E9.5 mouse embryos
using an anti-Tbx1 antibody. The enrichment of TBE1–2 and TBE3 regions is evaluated compared to an internal control, which is a primer pair
amplifying an ORF-free segment of mouse chromosome 14, and expressed as percentage of input. Values are from 3 experiments (mean6S.D.).
doi:10.1371/journal.pgen.1002571.g007
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Genotyping was carried out according to instructions provided by
the original reports.
All crosses were carried out in conventional, clean facilities in a
C57Bl6/129SvEv mixed genetic background.
Mouse embryo phenotyping
Embryos were examined after manual dissection under a stereo
microscope. In most cases we also carried histological sectioning of
paraffin-embedded specimens. Whole mount in situ hybridization
according to standard methods. Embryos were photographed and
then sectioned. In some cases we used images of sections for 3D
reconstruction using the Amira software.
Constructs and cell lines
P19CL6 cells were grown in Dulbecco-Modified Minimal
Essential Medium supplemented with 10% fetal bovine serum.
For cardiomyocytes differentiation the cells were plated at a
density of 5.0610
5 cells/well on a 35-mm tissue culture dish. The
next day, when cells reached ,90% confluence, the medium was
replaced with a growth medium containing 10 mM 5-Azacytidine
for 24 h [11]. After treatment with 5- Azacytidine, cells were
incubated in the growth medium containing 1.0% DMSO that
was changed daily in order to remove the cell debris resulting from
cell death. The experimental days were numbered consecutively
beginning from the day of treatment with 5- Azacytidine (day 0).
The generation of thestablytransfected celllinesP19-Tbx1-TEV-
PA and P19-TEV-PA has been described [30]. These cell lines have
been used for affinity purification experiments (see below).
For transient transfection, cells were cultured in 10 cm dishes
until 60–70% confluent and transfected with Fugene6 (Roche)
following the manufacturer protocol. Dharmacon ON-TARGET-
plus SMARTpool Baf60a/Smarcd1 siRNA was used to knock-
down Baf60a expression using Fugene6 transfection reagent. ON-
TARGETplus siCONTROL Non-targeting pool was used for
control transfections.
Protein extraction
P19Cl6 cells pelleted cells were resuspended in CE buffer
(10 mM HEPES, 60 mM KCl, 1 mM EDTA, 0.075% v/v NP40,
1 mM DTT and 1X protease inhibitors, pH 7.6), and centrifuged.
The nuclei were washed with 56pellet volumes of cold CE buffer
Figure 8. Tbx1 interacts with Baf60a and with Setd7, but not with p300 or Baf155. (A) Western blot analysis of affinity-purified nuclear
extracts and controls. For both panels, Lane 1: Affinity-purified material from P19-Tbx1-PA cells (constitutively expressing a Tbx1-TEV-ProteinA
construct); lane 2: nuclear extracts from the same cells; lane 3: affinity purified nuclear extracts from P19-PA cells (constitutively expressing a TEV-
Protein A construct as a negative control). Note that p300 is not retained in the affinity purified material (left panel, lane 1), while Baf60a is retained
(right panel, lane 1). (B) Western blot analyses of coimmunoprecipitation experiments with endogenous proteins from P19Cl6 cells.
Immunoprecipitation was carried out using an anti-Tbx1 antibody or rabbit IgG (control). Western blots were carried out using anti-Baf60a, anti-
Setd7, anti-p300, anti-Baf155 and anti-Tbx1 antibodies. CE: cytoplasmic extract (10% of input), NE: nuclear extracts (10% input).
doi:10.1371/journal.pgen.1002571.g008
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PLoS Genetics | www.plosgenetics.org 10 March 2012 | Volume 8 | Issue 3 | e1002571Figure 9. Tbx1 interacts with Baf60a in mouse embryo tissues. (A) Co-IP experiment showing interaction of the Tbx1 and Baf60a endogenous
proteins in embryo tissues. The first lane on the left contains nuclear extracts from E9.5 WT embryos. The second and third lanes contains nuclear
extracts from E9.5 Tbx1
2/2 and WT embryos immunoprecipitated with an anti-Baf60a antibody. Western blot with an anti-Tbx1 antibody clearly show
co-immunoprecipitation in the WT sample. (B) Whole mount in situ hybridization with an anti-sense and sense (control) Baf60a probe. Note a nearly
ubiquitous hybridization signal but with very little or no expression in the heart.
doi:10.1371/journal.pgen.1002571.g009
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(20 mM TrisHCl, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 25% Glycerol and 1X protease inhibitors, pH 8.0) was
added to the nuclear pellet and incubated on ice for 30 min.
Nuclear and cytosolic extracts were recovered spinning at
maximum speed for 30 min to pellet any nuclei.
Wound healing assay
P19Cl6 cells were cultured to confluent monolayer in 12-well.
Two hours before the experiment, we treated cells with mitomycin
c (10 mg/ml) and then we made a scratch wound using a standard
200-ml pipette tip. Wounded monolayers were washed with PBS
and digitally photographed for the 0 hour timepoint using an
inverted microscope equipped with a digital camera (Leica
AF6000LX time-lapse). Images of the wound were acquired every
30 min for 24 h. Subsequently, pictures were analyzed using the
‘‘Image J’’ software. The wound healing effect was calculated as
area wound closure compared with the area of the initial wound.
Briefly, the distance between the wound margins was measured at
0 hours and again every 4 hours post-wounding for 24 h.
12 hours post–wounding the following formula was used to
evaluate the area wound closure: distance
t=12h-distance
t=0h.
Data represent the average of at least 3 independent experiments
(2 wells/experiment).
Affinity purification
Native affinity purification was performed with strains P19-
Tbx1-PA and P19-PA as previously described [30,31]. Briefly,
nuclear extracts were transferred to Poly-Propylene Chromatog-
raphy Columns with IgG sepharose beads (Amersham) to capture
Tbx1-TEV-Protein A-containing complexes. Then, the columns
were subjected to protease TEV cleavage to release the Tbx1-
Figure 10. Baf60a occupies TBE regions of Wnt5a in P19Cl6 cells and embryo tissues. ChIP assays of P19Cl6 cells using anti-Baf60a
antibodies or mouse IgG. (A) Standard PCR results clearly show amplification from the Baf60a-immunoprecipitated material and from the input
sample but not from the IgG-immunoprecipitated material (negative control). (B) q-ChIP assay of E9.5 mouse embryos using an anti-Baf60a antibody.
The enrichment of TBE1–2 and TBE3 regions is evaluated compared to an internal control. (C) q-ChIP assay on a similar experiment as the one shown
in (A) but from P19Cl6 cells transfected with an empty vector (EV) or with a vector over-expressing Tbx1 (Tbx1), followed by quantitative real-time
PCR. The immunoprecipitation was carried out with an anti-Baf60a antibody. Note that the TBE regions are significantly more enriched in the Tbx1
overexpressing sample, indicating positive correlation between Tbx1 dosage and Baf60a occupation. Values are from 3 experiments (mean6S.D.).
Asterisks indicate statistically significant difference (P-value less than 0.05).
doi:10.1371/journal.pgen.1002571.g010
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transferred into PVDF membrane (Amersham) for Western
blotting analyses. The antibodies used for immunoblotting were
the monoclonal anti-Baf60a antibody (BD Biosciences, #611728)
and the anti-p300 (BD Biosciences, #554215).
Co-immunoprecipitation
For co-immunoprecipitation experiments, nuclear extracts of
P19Cl6 cells were quantified using a modified Bradford procedure
(Bio-Rad Laboratories, Hercules, CA). Approximately 100 mgo f
nuclear extracts were incubated with an anti Tbx1 antibody
(Abcam, #ab18530) or Baf60a antibody (BD Biosciences,
#611728) or rabbit/mouse IgG (Santa Cruz Biotechnology,
#2027) and then incubated with Protein A/G PLUS agarose
(Santa Cruz Biotechnology) at 4uC ON. The samples were washed
6 times with IPP150 (10 mM Tris-HCl, pH 8.0; 150 mM NaCl;
0.1% NP-40) and resuspended in SDS sample buffer. 10 mgo f
nuclear extracts (10% Input) and immunoprecipitated samples
were detected using Western blot analysis. We used anti-Baf60a
antibody (BD Biosciences, #611728), an anti-Setd7 antibody
(Abcam, #ab71214), anti-p300 (BD Biosciences, #554215) and
anti-SMARCC1/Baf155 (Abcam, #ab72503).
Chromatin immunoprecipitation
P19Cl6 cells were cross-linked using 1% formaldehyde at room
temperature for 15 min, and the reaction was stopped using
glycine at a final concentration of 0.125 M for 5 min. Cells were
then lysed in 1 ml of lysis buffer (10 mM HEPES, 60 mM KCl,
1 mM EDTA, 0.075% v/v NP40, 1 mM DTT and 1X protease
inhibitors, pH 7.6) on ice for 10 min, dounced using a 2 ml B
dounce to release nuclei. Isolated nuclei were suspended in Nuclei
lysis buffer (20 mM TrisHCl, 420 mM NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 25% Glycerol and 1X protease inhibitors,
adjusted to pH 8.0), incubated on ice for 30 min, washed in
nuclei lysis buffer and sonicated to obtain 200–500 bp. Sonicated
chromatin was immunoprecipitated 10 mg of a Tbx1 antibody
Figure 11. Tbx1 enhances H3K4 monomethylation of TBE regions of Wnt5a in cultured cells and in vivo. (A) ChIP assays of P19Cl6 cells
using an anti-H3K4me1 antibody or mouse IgG. DNA isolated from immunoprecipitated material was amplified by standard PCR with primers to
amplify the TBE1–2 and TBE3 regions of Wnt5a. The amplified PCR fragments were analyzed on 2% agarose gel. (B) q-ChIP assay from P19Cl6 cells
transfected with an empty vector (EV) or with a vector over-expressing Tbx1 (Tbx1), followed by quantitative real-time PCR. The immunoprecipitation
was carried out with an anti-H3K4me1 antibody. The enrichment of TBE1–2 and TBE3 regions is evaluated compared to an internal control. TBE
regions are significantly more enriched in the Tbx1 overexpressing sample, indicating that increased dosage of Tbx1 correlates with increased
methylation of H3K4 cross-linked to these DNA sequences. (C) q-ChIP assay from E9.5 Tbx1
2/2 and WT mouse embryos followed by quantitative real-
time PCR. The immunoprecipitation was carried out with an anti-H3K4me1 antibody. The enrichment of TBE1–2 and TBE3 regions is evaluated
compared to an internal control and expressed as percentage of input. Note the reduced enrichment of H3K4me1 at the Wnt5a TBE1–2 in Tbx1
2/2
embryos compared to WT. No change could be detected at the TBE3 locus. Values are from 3 experiments (mean6S.D.). Asterisks indicate statistically
significant difference (P-value less than 0.05).
doi:10.1371/journal.pgen.1002571.g011
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#611728), 2 mg of H3K4me1 antibody (Abcam, #ab8895), 2 mgo f
Dimethyl-Histone H3 (Lys4) (Millipore, #07-030), 5 mg of Anti-
trimethyl-Histone H3 (Lys4) (Millipore, #07-473), 5 mg of Anti-
acetyl-Histone H3 (Millipore, #06-599), or normal rabbit/mouse
IgG (Santa Cruz Biotechnology, #2027). Samples were then
incubated with 20 ml of protein A/G PLUS agarose (Santa Cruz
Biotechnology) at 4uC ON. The samples were extensively washed
and incubated in an elution buffer (1% SDS and 0.1 M NaHCO3)
at 30uC for 20 min. Cross-linking of protein-DNA complexes was
reversed at 65uC ON, followed by treatment with DNase-fre RNase
A for 30 min at 37uC and 100 mg/ml proteinase K for 2 h at 55uC.
Phenol/chloroform-extracted, and ethanol-precipitated DNA was
resuspended in 50 ml of H2O and subjected to PCR amplification
(see below). ChIP experiments using embryo tissue was carried out
as follows. WT and Tbx1
2/2 E9.5 mouse embryos were dissected,
their heads were cut off and the trunks were stored at 280uC. Pools
of 5 embryos were used for each ChIP experiment. Each ChIP
experiment was performed using 5 mg of H3K4me1 (Abcam,
#ab8895), 10 mg of TBX1 antibody (Abcam, #ab18530) and 5 mg
or 10 mg of normal rabbit IgG (Santa Cruz Biotechnology, #2027)
as negative control with the LowCell ChIP Kit (Diagenode). In
brief, the embryos were fixed in 1% formaldehyde at room
temperature for 15 min and then glycine was added to stop the
reaction to a final concentration of 0.125 M for 5 min. Subse-
quently, embryos were washed with PBS, disaggregated by dounce
homogenization in cold PBS and then resuspended in cell lysis
buffer (5 mM PIPES pH 8.0, 85 mM KCl, 0.5% Igepal supple-
mented with protease inhibitors). Next, nuclei were resuspended in
130 ml of Buffer B (LowCell ChIP Kit reagent) and chromatin was
sheared into 200–500 bp long fragments using the Covaris S2
SamplePreparationSystem(DutyCycle:5%,Cycles:6,Intensity:2,
Figure 12. Effects of Tbx1 on H3K4 di- and tri-methylation and H3 acethylation status of the TBE regions of Wnt5a. q-ChIP assay from
P19Cl6 cells transfected with an empty vector (EV) or with a vector over-expressing Tbx1 (Tbx1) followed by quantitative real-time PCR. The
immunoprecipitation was carried out with anti-H3K4me2, anti-H3K4me3 or anti-AcH3 antibodies. (A) TBE1/2 region, (B) TBE3 region, and (C) p16
promoter region (positive control). There is no enrichment for any of these histone modifications at the TBE regions. Values are from 3 experiments
(mean6S.D.).
doi:10.1371/journal.pgen.1002571.g012
Figure 13. Tbx1 requires Baf60a to regulate target genes. P19Cl6 cells were transfected with empty vector or Tbx1-expression vector (Tbx1-
3HA) and an anti-Baf60a siRNA or control siRNA. The western blot shown on the top panel shows the efficiency of the knock-down experiment. The
histograms represent quantitative real-time PCR evaluation of the expression of Tbx1 (in black) and of 4 target genes at the experimental points
indicated. In all cases, Baf60a knock-down abolishes the Tbx1-driven upregulation of these target genes. Values are from 3 experiments (mean6S.D.).
Asterisks indicate statistically significant difference (P-value less than 0.05).
doi:10.1371/journal.pgen.1002571.g013
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Sweeping, Cycle Time: 60 seconds, Degassing mode: Continuous).
Following steps included incubation of the sheared chromation with
antibody coated beads over night, several washing steps and reverse
crosslinking. Next, equal DNA amounts of input and immunopre-
cipitated DNA were initially used as a template for conventional
PCR amplification of the TBE1–2 region of Wnt5a (Wnt5a TBE1–
2_1_F 59-CTTCCCCTGGTGTGGATATG-39, Wnt5a TBE1–
2_1_R 59-AGAGGCTCCTTCCAGTCCTC-39) and TBE3 re-
gion (wnt5a TBE-3_1_F 59-ACTGCTGGTAGGGCAGAAAA-39,
wnt5a TBE-3_1_R 59-TCAGGCACCATTAAACCACA-39).
For quantitative ChIP, we next carried out real-time PCR of the
immunoprecipitated DNA and inputs, using the FastStart Universal
SYBR Green Master kit (Roche) and the 7900HT Fast Real-Time
PCR System (Applied Biosystems). ChIP signals were normalized to
that of an internal control amplimer that we have selected from an
ORF-free region of mouse chromosome 14 (INT-XIV-1F 59-
TTCTTGTCCACAGCCCTCTT-39, INT-XIV-1R 59-TGGTG-
GAAGAGGAGACATCC-39).PCRefficiencies were determined for
each primer pair using standard curves. PCR was carried out on 2 ml
of 1/100 dilution of the input or 2 ml of immunoprecipitated samples.
Expression and purification of GST-Tbx1 fusion proteins
A GST-Tbx1 expression vector was kindly provided by Dr.
Amendt (IBT, Texas A&M University, Houston, TX USA) and
transformed into E. coli BL21(DE3) cells. Protein synthesis was
induced by the addition of IPTG to a final concentration of
0.1 mM. GST pull-down assay was performed using ProFound
Pull-Down GST Protein: Protein Interaction Kit (PIERCE).
RNA extraction, cDNA synthesis, and Q-RT-PCR
RNA was extracted from P19Cl6 cells using TRI-Reagent
(Ambion/Applied Biosystems) according to the manufacturer’s
protocol. Extracted RNA was treated with DNA-free Kit
(Ambion/Applied Biosystems). cDNA was synthesized from 2 mg
total RNA (normalized via UV spectroscopy) using the High
Capacity cDNA Reverse Transcription Kit, according to the
manufacturer’s instructions (Applied Biosystems). Target cDNA
levels were compared by Q-RT-PCR in 20-ml reactions containing
16 SYBR green (Applied Biosystems), 100 mm of each primer,
and we used the 7900HT Fast Real-Time PCR System (Applied
Biosystems). Results were normalized against glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) expression, unless otherwise
indicated. Relative expression was evaluated using the delta-delta-
cycle threshold method.
Supporting Information
Figure S1 Expression analyses by quantitative real time PCR of
genes Tbx1, Wnt5a, Baf60a/Smarcd1 and Baf60c/Smarcd3 in
undifferentiated P19Cl6 cells (day 0) and during the first 5 days
of treatment to induce differentiation.
(TIF)
Figure S2 In vitro, wound healing assay performed on P19Cl6
cells before and after Wnt5a knock-down by siRNA. (A) Western
blot demonstrating knock-down of Wnt5a expression. (B) Micro-
photographs of the wound healing assay on P19Cl6 cells. (C)
Summary of results expressed as area of closure with and without
Wnt5a over time, up to 24 hours. Data were obtained by time-
lapse microscopy. Control cells recover a significantly larger area
after the wound (P=0.01, t-test).
(TIF)
Figure S3 Tbx1 and Wnt5a gene expression analysis by
quantitative real time PCR assay in cells expressing Tbx1 after
transfection withthe indicated amounts of a Tbx1 expression vector.
Each data point is expressed as the mean of three replicates 6 SD.
(TIF)
Figure S4 (A) Western blot analyses of coimmunoprecipitation
experiments using the anti-HA-immunoprecipitation kit. P19Cl6
cells were co-transfected transiently with Tbx1-3HA and Baf60c-
Flag expression vectors). Western blots were carried out using anti-
HA and anti-Flag antibodies. NE: nuclear extracts (10% input). (B)
Direct interaction assay using GST pull-down shows that Tbx1
interacts with Baf60a. Western blot analysis of GST-Tbx1 pull-
down from a lysate of P19Cl6 cells overexpressing Baf60a. The
input lane shows Tbx1 expression in the lysate.
(TIF)
Figure S5 Quantitative real-time PCR evaluation of the
expression of Tbx1, Cyp26a1, Fgf8, Fgf10, and Wnt5a with and
without Baf60a knock-down by siRNA in undifferentiated P19Cl6
cells. Note that the knock-down of Baf60a has no significant effect
on the expression of these genes (P-value more than 0.052.
(TIF)
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